工商銀行(01398.HK)擬向工銀投資增資不超300億元
格隆匯12月23日丨工商銀行(01398.HK)公告,經2020年12月23日本行董事會審議通過,本行擬向全資子公司工銀投資增資,增資金額不超過人民幣300億元,上述對工銀投資的增資分次進行。
工銀投資是本行全資子公司,主要經營範圍包括開展市場化、法治化債轉股及配套支持業務;依法依規面向合格社會投資者募集資金,用於支持實施市場化債轉股;發行金融債券;與債轉股業務相關的財務顧問和諮詢業務;以及經國務院銀行業監督管理機構批准的其他業務等。
本行將以自有資金進行本次增資。本次增資無需提交股東大會審議,不屬於本行關聯交易或重大資產重組事項。本次增資尚需經中國銀行保險監督管理委員會批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.